The American Society of Clinical Oncology and the College of American Pathologists have updated their clinical practice guideline for HER2 testing in breast cancer to include five clinical recommendations related to ISH and IHC assays. READ MORE
Comparative Effectiveness Study Examines Safety, Efficacy of Biosimilar in Clinical Trial, Real-World Practice
The results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat chemotherapy-induced neutropenia in patients with breast cancer.
Widespread use of alternative payment models may improve the quality of breast and colorectal cancer screening programs.
A study presented at the ASCO Cancer Survivorship Symposium evaluated the impact of a breast cancer survivorship model on health system resources and costs.
The rate of mammogram use increased by nearly 6% among older patients who were recommended for screening after the Affordable Care Act eliminated co-payments.
Adam M Brufsky, MD, PhD, discusses some of the key topics and data for examining the clinical and cost implications of HER-positive breast cancer care in the value-based care era.
Research in Review
Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy.
The American Society of Clinical Oncology and the College of American Pathologists have updated their clinical practice guideline for HER2 testing in breast cancer to include five clinical recommendations related to ISH and IHC assays.
The American Society of Clinical Oncology announced its support of the Society for Integrative Oncology evidence-based guideline on the use of integrative therapies during and after breast cancer treatment.
The National Comprehensive Cancer Network has released new guidelines for screening follow-up, ultrasound findings, and other breast cancer considerations.
The American Society for Radiation Oncology has issued a clinical guideline for the use of whole-breast radiation therapy that expands the eligibility criteria for hypofractionated therapy.
The 40th Annual San Antonio Breast Cancer Symposium will take place from December 5-9 in the Henry B Gonzalez Convention Center. Breast cancer clinicians and researchers will convene to discuss cutting-edge treatment options and novel strategies for managing breast cancer.
Researchers conducted a study to generate estimates of costs associated with breast cancer adjuvant chemotherapy regimens.